These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Carrier detection and prenatal diagnosis in haemophilia A and B. Chistolini A; Papacchini M; Mazzucconi MG; La Verde G; Arcieri R; Ferrari A; Paesano R; Pachi A; Mariani G Haematologica; 1990; 75(5):424-8. PubMed ID: 1982946 [TBL] [Abstract][Full Text] [Related]
44. Molecular diagnosis of hemophilia A and B. Report of five families from Costa Rica. Salazar-Sánchez L; Jiménez-Cruz G; Chaverri P; Schröder W; Wulff K; Jiménez-Arce G; Sandoval M; Ramírez P; Herrmann FH Rev Biol Trop; 2004 Sep; 52(3):521-30. PubMed ID: 17361545 [TBL] [Abstract][Full Text] [Related]
45. F8 and F9 mutations fail to co-segregate in a family with co-incident haemophilia A and B. Siddiq S; Morse C; Goodeve A; Panayi M; Tait RC; Mumford A Haemophilia; 2011 Jan; 17(1):e230-4. PubMed ID: 20860608 [TBL] [Abstract][Full Text] [Related]
46. Unexpected haemophilia despite pre-natal testing - a combined haemophilia A and haemophilia B family. Roy NBA; Curry N; Keeling D Br J Haematol; 2017 Oct; 179(2):182. PubMed ID: 28677841 [No Abstract] [Full Text] [Related]
47. Gene therapy for hemophilia: the clot thickens. High KA Hum Gene Ther; 2014 Nov; 25(11):915-22. PubMed ID: 25397928 [No Abstract] [Full Text] [Related]
48. Heteroduplex analysis in hemophilia B: detection of two novel factor IX gene mutations. Driscoll MC; Chu A; Hilgartner MW Am J Hematol; 1996 Apr; 51(4):324-7. PubMed ID: 8602635 [TBL] [Abstract][Full Text] [Related]
49. Molecular genetics and counselling in haemophilia. Peake I Thromb Haemost; 1995 Jul; 74(1):40-4. PubMed ID: 8578494 [TBL] [Abstract][Full Text] [Related]
50. Association of factor VIII and factor IX mutations, HLA Class II, tumour necrosis factor-α and interleukin-10 on inhibitor development among Thai haemophilia A and B patients. Chuansumrit A; Sasanakul W; Sirachainan N; Kadegasem P; Wongwerawattanakoon P; Mahaklan L; Nathalang O Haemophilia; 2017 Nov; 23(6):e518-e523. PubMed ID: 28891589 [No Abstract] [Full Text] [Related]
51. Deficiencies in factors IX and VIII: what is now known. Kurachi K; Yao SN; Furukawa M; Kurachi S Hosp Pract (Off Ed); 1992 Feb; 27(2):41-51. PubMed ID: 1735764 [TBL] [Abstract][Full Text] [Related]
52. Factor VIII and IX genes polymorphisms in a Brazilian black population. Arruda VR; Annichino-Bizzachi JM; Sonati Mde F; Costa FF Thromb Haemost; 1993 Aug; 70(2):371. PubMed ID: 7901921 [No Abstract] [Full Text] [Related]
53. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Miller CH; Benson J; Ellingsen D; Driggers J; Payne A; Kelly FM; Soucie JM; Craig Hooper W; Haemophilia; 2012 May; 18(3):375-82. PubMed ID: 22103590 [TBL] [Abstract][Full Text] [Related]
54. Haemophilia A/B carriers: haemorrhagic burden of disease and open issues. Pasca S; Zanon E Blood Transfus; 2020 Nov; 18(6):496-497. PubMed ID: 32955424 [No Abstract] [Full Text] [Related]
56. The hemophilias. Green PM; Naylor JA; Giannelli F Adv Genet; 1995; 32():99-139. PubMed ID: 7741026 [No Abstract] [Full Text] [Related]
57. [Possibilities of detection of haemophilia carriers (author's transl)]. Marbet GA; Marbet B; Duckert F Ther Umsch; 1979 Apr; 36(4):334-40. PubMed ID: 451952 [No Abstract] [Full Text] [Related]
58. Recent advances in the management of the child who has hemophilia. Dunn AL; Abshire TC Hematol Oncol Clin North Am; 2004 Dec; 18(6):1249-76, viii. PubMed ID: 15511615 [TBL] [Abstract][Full Text] [Related]
59. [Physiopathology and therapy of hemophilia and von Willebrand's disease]. Fukui H Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):866-74. PubMed ID: 1919201 [No Abstract] [Full Text] [Related]